Status:
COMPLETED
Diet and Hypertension Management in African Americans With Chronic Kidney Disease
Lead Sponsor:
Duke University
Conditions:
Chronic Kidney Diseases
High Blood Pressure
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine cultural and disease-related barriers and facilitators to following the Dietary Approaches to Stop Hypertension (DASH) dietary pattern among Black Americans w...
Detailed Description
Excess cardiovascular disease (CVD) mortality among Black Americans with CKD is a significant US public health disparity. Compared to their White counterparts, Blacks develop CKD earlier in life and B...
Eligibility Criteria
Inclusion
- Black race (self-identified)
- ≥21 years old
- CKD defined as an eGFR of 30-59 ml/min/1.73m2
Exclusion
- History of kidney transplant
- Pregnant of breast-feeding
- Risk factors for hyperkalemia including insulin-dependent diabetes mellitus, diabetes with poor blood glucose control (A1C \>10), baseline serum potassium ≥4.8 mg/dl, and serum bicarbonate \<18 mg/dl
- History of hypertension in the preceding 6 months defined as serum potassium greater than 5.1 mg/dl
- Risk for hypotension or severe hypertension (SBP \<120 or ≥180 or DBP ≥110 mmHg)
- History of kidney transplant
- Lack of English language proficiency
Key Trial Info
Start Date :
April 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 27 2023
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04084574
Start Date
April 14 2022
End Date
September 27 2023
Last Update
January 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27710